BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 4017948)

  • 1. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.
    Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH
    Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.
    Liang T; Heiss CE; Cheung AH; Reynolds GF; Rasmusson GH
    J Biol Chem; 1984 Jan; 259(2):734-9. PubMed ID: 6693392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
    Kadohama N; Karr JP; Murphy GP; Sandberg AA
    Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
    Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A
    Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
    Liang T; Heiss CE
    J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.
    Hirosumi J; Nakayama O; Fagan T; Sawada K; Chida N; Inami M; Takahashi S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):357-63. PubMed ID: 7734404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17 beta-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5 alpha-reductase.
    Di Salle E; Briatico G; Giudici D; Ornati G; Nesi M; Panzeri A
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):765-8. PubMed ID: 1373305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
    Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate.
    Span PN; Schalken JA; Sweep FG; Smals AG
    Prostate; 1998 Feb; 34(3):222-30. PubMed ID: 9492851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
    Liang T; Rasmusson GH; Brooks JR
    J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of steroid 5 alpha-reductase of rat liver and prostate microsomes.
    Liang T; Cheung AH; Reynolds GF; Rasmusson GH
    J Biol Chem; 1985 Apr; 260(8):4890-5. PubMed ID: 3988737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
    Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
    Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.
    Rasmusson GH; Reynolds GF; Steinberg NG; Walton E; Patel GF; Liang T; Cascieri MA; Cheung AH; Brooks JR; Berman C
    J Med Chem; 1986 Nov; 29(11):2298-315. PubMed ID: 3783591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.
    Li X; Singh SM; Labrie F
    J Med Chem; 1995 Mar; 38(7):1158-73. PubMed ID: 7707319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase.
    Bratoeff E; Sainz T; Cabeza M; Heuze I; Recillas S; Pérez V; Rodríguez C; Segura T; Gonzáles J; Ramírez E
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):48-56. PubMed ID: 17629476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide (4-MA) and (4R)-5,10-SECO-19-norpregna-4,5-diene-3,10,20-trione (SECO) on androgen biosynthesis in the rat testis and epididymis.
    Cooke GM; Robaire B
    J Steroid Biochem; 1986 Apr; 24(4):877-86. PubMed ID: 3702462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5 alpha-reductase and comparison of two inhibitors.
    Toomey RE; Goode RL; Petrow V; Neubauer BL
    Prostate; 1991; 19(1):63-72. PubMed ID: 1876537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate. III--A structural feature characteristic of the rat prostate 5 alpha-reductase active site.
    Petrow V; Padilla GM; McPhail AT; Bruchovsky N; Schneider SL
    J Steroid Biochem; 1989 Mar; 32(3):399-407. PubMed ID: 2704237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor expression and 5 alpha-reductase activity along the proximal-distal axis of the rat prostatic duct.
    Prins GS; Cooke PS; Birch L; Donjacour AA; Yalcinkaya TM; Siiteri PK; Cunha GR
    Endocrinology; 1992 May; 130(5):3066-73. PubMed ID: 1572313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
    Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.